Your browser doesn't support javascript.
loading
[Efficacy and safety of dexcitabine combined with HAAG regimen in the treatment of recurrent acute myeloid leukemia].
Wu, X F; Li, C C; Li, T T; Sun, L; Lu, J; Ran, X H.
Affiliation
  • Wu XF; Department of Hematology, People's Hospital Affiliated to Shandong First Medical University, Jinan 271199, China.
  • Li CC; Department of Hematology, People's Hospital Affiliated to Shandong First Medical University, Jinan 271199, China.
  • Li TT; Department of Hematology, People's Hospital Affiliated to Shandong First Medical University, Jinan 271199, China.
  • Sun L; Department of Hematology, People's Hospital Affiliated to Shandong First Medical University, Jinan 271199, China.
  • Lu J; Department of Hematology, People's Hospital Affiliated to Shandong First Medical University, Jinan 271199, China.
  • Ran XH; Department of Hematology, Weifang People's Hospital of Shandong Province, Weifang 261042, China.
Zhonghua Yi Xue Za Zhi ; 103(13): 981-985, 2023 Apr 04.
Article in Zh | MEDLINE | ID: mdl-36990713

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Receptors, Urokinase Plasminogen Activator Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: Zh Journal: Zhonghua Yi Xue Za Zhi Year: 2023 Document type: Article Affiliation country: China Country of publication: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Receptors, Urokinase Plasminogen Activator Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: Zh Journal: Zhonghua Yi Xue Za Zhi Year: 2023 Document type: Article Affiliation country: China Country of publication: China